Genetic Technologies Limited (GTG)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Genetic Technologies Limited
Stock Code: GTG
Website: www.gtglabs.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 11
Equiv. Shares (M): 813

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.015 $ 0.014 $ 0.015 $ 0.014 $ 0.014 60,806 $ 0.001  7.143 %

Company Overview

Business Description:
Genetic Technologies Limited (GTG) is a biotechnology company engaged in genetic testing service business, licensing its intellectual property relating to non-coding DNA and conducting research activities on the impact of DNA on health. GTG has operations in Australia, China, Canada, Switzerland and USA. Its primary focus is diagnostic products for cancer management. GTG provides genetic tests products & services in three areas: Medical, Paternity and Animal.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -10.1 -1.8 -- 0.0 0.0 0.0 --
2013  A -9.3 -2.0 -- 0.0 0.0 0.0 --
2012  A -10.4 -2.3 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Bionomics (BNO) $175 M -- 6.3117 0.3108 54.5455 7.4600 5.6911 0.00 0.00 0.00
CSL (CSL) $40,487 M 0.0899 0.2398 0.0991 29.8526 24.0795 21.9077 1.41 1.77 1.88
Genetic Technologies (GTG) $11 M -- -- -- -- -- -- 0.00 -- --
Mesoblast (MSB) $1,303 M -- -- -- -- -- -- 0.00 0.00 0.00
Sirtex Medical (SRX) $1,462 M 0.2906 0.5174 0.3448 62.6392 41.2797 30.6953 0.54 0.65 1.04

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
GTG -- -- 5.19 -- 1.47
Market 1.02 13.7 0.96 0.99 2.90
Sector 0.81 16.3 2.51 1.44 7.24

Directors
Name Position Start Date
Professor Ian McKenzie Non-Executive Director 29 November 2013
Mr David Noel Carter Non-Executive Director 24 September 2014
Mr Grahame Leonard Non-Executive Director 29 November 2013
Dr Paul Kasian Non-Executive Director 12 December 2013
Dr Lindsay Peter Wakefield Non-Executive Director 24 September 2014
Dr Malcolm Roy Brandon Non-Executive Director,Non-Executive Chairman 05 October 2009

Management
Name Position
Alison Mew Chief Executive Officer
Eutillio Buccilli Chief Financial Officer
M. Luisa Ashdown Director of Global Licensing and Intellectual Property
Bronwyn Chrisite Financial Controller,Company Secretary
Diana Newport Quality and Business Operations Director
Dr Richard Allman Scientific Director
Mark J Ostrowski Sr. VP Sales and Marketing - Phenogen Sciences Inc.

Calendar of Events
Date Event
29 October 2015 Report (Annual)
27 October 2015 Report (Quarterly)
26 October 2015 Report (Annual)
28 August 2015 Report (Prelim)
19 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Trading Using Options and Minis

This guide to using options and MINIs to improve the results of your trading is for those with some experience in trading shares.

More details...

News

Markets melt up

By Michael McCarthy (chief market strategist, CMC Markets) 19/12/2014 | Traders and investors caught short heading into the FOMC scrambled for cover in Europe and the US, in many cases driving indices to their best one day performance for 2015.

Aussie Investors take their foot off the accelerator

By Betty Lam (Sales Trader, CMC Markets) 18/12/2014 | Lead by the Fed-fervour offshore, Australians shares jumped on the Yellen cheer wagon. The material and energy stocks were back in vogue as both sectors gained over 3% in morning trade.

Fed Feeds Frenzy

By Michael McCarthy (chief market strategist, CMC Markets) 18/12/2014 | In spite of a frenzied pre-mortem, a benign statement from the US Federal Reserve’s Open Market Committee and steadying commodity markets drove investors back into share markets overnight. A calmer, stronger ruble helped offset European growth fears, highlighted in the overnight session by further declines in inflation.

Household brands Woolworths and Telstra Heavy Lifting

By Betty Lam (Sales Trader, CMC Markets) 11/12/2014 | Offshore jitters sent ripples through to Australian stocks. The open saw the local equities take 65 points off the index, catalysed by a mass-exit in energy stocks, yet again.

Steady open as Woodside investors wait on details of possible Wheatstone acquisition

By Ric Spooner (Chief Market Analyst, CMC Markets) 10/12/2014 | Yesterday’s news on Greek politics and China’s bond market came at a time when US and European stock markets have extended rallies and pushed valuations higher. This makes those markets vulnerable to downward corrections as profit takers act to avoid missing out.

MYEFO and Lima - December could be nasty.

BR Securities Australia Pty Ltd 2/12/2014 | December 2014 could go down as a nasty moment in Australian finance. MYEFO will reveal a deteriorating budget deficit and the UNFCCC meeting in Lima, Peru will provide the agreement, to be ratified in Paris in 2015, on how much (or little) CO2 is to be allowed into the atmosphere from 2020.

More...


Sponsored Links